[PTX] QoQ Quarter Result on 31-Dec-2023 [#Q2]

Stock
[PTX] Prescient Therapeutics Limited
Announcement Date
29-Dec-2023
Financial Year
2024
Quarter
31-Dec-2023 [#Q2]
Profit Trend
QoQ- 12.27%
YoY- -25.66%
Quarter Report
PTX's Result
PTX's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/12/23 30/06/23 31/12/22 30/06/22 31/12/21 30/06/21 CAGR
Revenue 1,773 1,940 1,174 1,255 1,047 842 538 48.75%
PBT -6,391 -5,559 -5,288 -4,084 -3,440 -3,428 -2,938 29.53%
Tax -1,773 -1,940 -1,164 -1,205 -939 -812 -588 44.42%
NP -4,619 -3,619 -4,125 -2,880 -2,501 -2,616 -2,350 25.23%
Tax Rate - - - - - - - -
Total Cost 6,391 5,559 5,298 4,134 3,548 3,458 2,888 30.28%
Ratio Analysis
30/06/24 31/12/23 30/06/23 31/12/22 30/06/22 31/12/21 30/06/21 CAGR
NP Margin -260.56 -186.59 -351.49 -229.53 -238.94 -310.50 -437.20 -15.83%
Per Share
30/06/24 31/12/23 30/06/23 31/12/22 30/06/22 31/12/21 30/06/21 CAGR
EPS -0.01 -0.00 -0.01 -0.00 -0.00 -0.00 -0.00 -
EPS Diluted -0.01 -0.00 -0.01 -0.00 -0.00 -0.00 -0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.